Herbal medicines as potential inhibitors of SARS-CoV-2 infection

(2022) Herbal medicines as potential inhibitors of SARS-CoV-2 infection. Curr Pharm Des. ISSN 1381-6128

Full text not available from this repository.

Abstract

Coronavirus disease 2019 (COVID-19) is the result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Understanding molecular pathogenesis is an essential factor for the allocation of effective preventive measures and the development of targeted therapeutics against COVID-19. The genome of SARS-CoV-2 encodes structural and nonstructural proteins, which can be targets for compounds with potential therapeutic ability. On the other hand, the virus life cycle has stages susceptible to targeting by drug compounds. Many natural antiviral compounds have been studied and evaluated at the cellular and molecular levels with antiviral potential. Meanwhile, many studies over the past few months have shown that plant polysaccharides have good ability to target proteins and stages of the virus life cycle. In this regard, in this review study, the virus specifications and infectious process and structural and functional components of SARS-CoV-2 will be reviewed, and then the latest studies on the effect of plant compounds with more focus on polysaccharides on viral targets and their inhibitory potential on the infectious process of COVID-19 will be discussed.

Item Type: Article
Keywords: Alkaloids Covid-19 Herbal medicines Polyphenols Polysaccharides SARS-CoV-2 Terpenes.
Journal or Publication Title: Curr Pharm Des
Journal Index: Pubmed
Identification Number: https://doi.org/10.2174/1381612828666220802121014
ISSN: 1381-6128
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/16598

Actions (login required)

View Item View Item